eu-project-H2020-diabetes-lsfm4life

The LSFM4LIFE project

The aim of LSFM4LIFE is the isolation and therapeutic-scale manufacture of human pancreas organoids for the cellular therapy of type 1 diabetes (T1D). Pancreas organoids, which are grown from adult stem cells, are a small in vitro version of pancreas. The production of pancreas organoids from adult stem cells has been established in 2013.

Sparks & Co is work package leader for this project.

4 years

8 partners

6 countries

5.1 million funding